Given the critical role of the tumor microenvironment in modulating immune responses (26), ASCL1’s association with various immunomodulatory factors—including cytokines, immunomodulators, MHC molecules, and receptors—was assessed across multiple cancers, including BC. This evidence concerns the gene ASCL1 and breast cancer.